IL6 and polycystic ovary syndrome: Chiming in with this finding, there are plenty of data available in the existing literature which link PCOS to autoimmune markers.9,10 Increased inflammatory responses and over expression of immune modulators have already been reported in these patients.11 Fulghesu et al.12 recently reported that monocytes of patients with insulin-resistant PCOS produce significant amounts of interleukin-6 (IL6), a potent inflammatory cytokine, in response to lipopolysaccharide (LPS).